who's who

5 Houston innovators headed to SXSW to know this weekend

Meet five of the many Houston innovators that will be out at SXSW Pitch, Houston House, Founded in Texas, and much more this week and into next week. Photos courtesy

Editor's note: It's a special Friday edition of innovators to know this week — well, weekend. SXSW kicks off today and Houstonians will be headed up to Austin for the week or just the weekend. If you're looking out for the best panels and talks to go to, look no further than this guide I created — as well as the five Houston innovators I think you should know who are listed below.

Lara Cottingham, chief of staff for Greentown Labs

Photo via LinkedIn

Calling all energy transition startups, investors, and more. The Greater Houston Partnership is hosting a full day of energy transition discussions at Houston House on Monday, March 14, at the Line Hotel. Lara Cottingham of Greentown Labs will be at the activation site with a must-attend networking hour at 4 pm called Transition on Tap.

Diana Murakhovskaya, co-founder and general partner of The Artemis Fund

Photo via LinkedIn

Who runs the world? Women. And Diana Murakhovskaya knows that based off her work with her Houston-based venture capital fund, The Artemis Fund. Project W, Artemis Fund, HearstLab, and Beam have teamed up at SXSW to present the second Founded in Texas event on Sunday, March 13, at Relay Coworking. Twelve founders selected by application will pitch to investors from across the country . The audience will get a glimpse of the innovation and creativity at work in the growing Texas startup ecosystem.

Pamela Singh, co-founder and CEO of CaseCTRL

Photo courtesy of CaseCTRL

Pamela Singh is the only Houston startup founder to pitch this year at SXSW's pitch competition. Representing her digital health startup, Case CTRL, Singh takes the prestigious stage Saturday, March 12, to compete in the Enterprise & Smart Data Technology category.

Sandy Guitar, managing director of HX Venture Fund

Photo courtesy of Sandy Guitar

The HX Venture Fund is hosting a meetup that all of the Houston startup ecosystem needs to know about. Network with a number of founders from Houston's fastest-growing startups along with several great VCs around the nation to participate in a joint conversation about founding tech startups. The event will take place at 11:30 am to 12:30 pm at Hilton Austin Downtown, Room 408.

Ashley DeWalt, managing director of DivInc

Photo courtesy of DivInc

Ashley DeWalt, managing director of DivInc, is just one of the many Houston innovators featured in Houston House from the GHP. The activation starts Sunday, March 13, at the Line Hotel with a day of programming across industries and topics — from sports tech and diversity (both topics DeWalt specializes in) to health care innovation and space. Catch DeWalt's panel, Game Changers - The Rise of Sports Tech, on Sunday at 11:30 am at Houston House.

Trending News

Building Houston

 
 

InformAI has three AI-based products geared at improving health care. Photo via Getty Images

In Houston, we’re lucky to have top-tier doctors in the Texas Medical Center, ready to treat us with the newest technology. But what about our family members who have to rely on rural hospitals? Thanks to one Houston company, doctors in smaller community hospitals may soon have new tools at their disposal that could improve outcomes for patients around the world.

Since InnovationMap last caught up with Jim Havelka, CEO of InformAI, two years ago, that hope has come far closer to a reality. InformAI is a VC-backed digital health company. Part of JLABS @ TMC innovation facilities, the company uses artificial intelligence to develop both diagnostic tools and clinical outcome predictors. And two of the company’s products will undergo FDA regulatory testing this year.

SinusAI, which helps to detect sinus-related diseases in CT scans, received its CE Mark — the European equivalent of FDA approval — last year and is being sold across the Atlantic today, says Havelka. He adds that in the United States alone, there are roughly 700,000 sinus surgeries that the product is positioned to support.

Another product, RadOnc-AI, is designed to help doctors prescribe radiation dose plans for head and neck cancers.

“Ideally the perfect plan would be to provide radiation to the tumor and nothing around it,” says Havelka. “We’ve built a product, RadOnc-AI, which autogenerates the dose treatment plan based on medical images of that patient.”

It can be an hours-long process for doctors to figure out the path and dose of radiation themselves, but the new product “can build that initial pass in about five minutes,” Havelka says.

That in itself is an exciting development, but because this technology was developed using the expertise of some of the world’s top oncologists, “the first pass plan is in line with what [patients would] get at tier-one institutions,” explains Havelka. This creates “tremendous equity” among patients who can afford to travel to major facilities and those that can’t.

To that end, RadOnc-AI was recently awarded a $1.55 million grant from the Cancer Prevention and Research Institute of Texas, or CPRIT, a state agency that funds cancer research. The Radiological Society of North America announced late last year that InformAI was named an Aunt Minnie Best of Radiology Finalist.

“It’s quite prestigious for our company,” says Havelka. Other recent laurels include InformAI being named one of the 10 most promising companies by the Texas Life Science Forum in November.

And InformAI is only gaining steam. A third product is earlier in its stage of development. TransplantAI will optimize donor organ and patient recipient matches.

“A lot of organs are harvested and discarded,” Havelka says.

His AI product has been trained on a million donor transplants to help determine who is the best recipient for an organ. It even takes urgency into account, based on a patient’s expected mortality within 90 days. The product is currently a fully functional prototype and will soon move through its initial regulatory clearances.

The company — currently backed by three VC funds, including DEFTA Partners, Delight Ventures, and Joyance Partners — is planning to do another seed round in Q2 of 2023.

“We’ve been able to get recognized for digital health products that can be taken to market globally,” says Havelka.

But what he says he’s most excited about is the social impact of his products. With more money raised, InformAI will be able to speed up development of additional products, including expanding the cancers that the company will be targeting. And with that, more and more patients will one day be treated with the highest level of care.

Trending News